NP35925 Cardiovascular & Respiratory Medicines

Estimated value

goods

Awarded value

Suppliers

85

8 SME

Lots

15

15 awarded

Published

06 May 2025

Total lots

15

Awarded

15

0 pending

Estimated total

£93.7m

Awarded total

Lot 2cancelled

Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials

Award value

Start

End

Estimated

£4.5m

CPV

33600000
Awarded to 1 supplier
Lot 19cancelled

All Other Cardiovascular & Respiratory Medicines

Award value

Start

End

Estimated

£34.4m

CPV

33600000
Lot 3cancelled

Epinephrine (Adrenaline) Pre-Filled Syringes

Award value

Start

End

Estimated

£1.6m

CPV

33600000
Awarded to 2 suppliers
Lot 5cancelled

Enoxaparin Sodium Injection

Award value

Start

End

Estimated

£15.3m

CPV

33600000
Lot 7cancelled

Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets

Award value

Start

End

Estimated

£192k

CPV

33600000
Lot 8cancelled

Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets

Award value

Start

End

Estimated

£119k

CPV

33600000
Lot 9cancelled

Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets

Award value

Start

End

Estimated

£62k

CPV

33600000
Awarded to 1 supplier
Lot 10cancelled

Nifedipine Modified-Release (M/R) Capsules and Tablets

Award value

Start

End

Estimated

£137k

CPV

33600000
Lot 12cancelled

Branded and Branded Generic Inhalers

Award value

Start

End

Estimated

£4.9m

CPV

33600000
Lot 13cancelled

Iloprost Medicines

Award value

Start

End

Estimated

£1.6m

CPV

33600000
Awarded to 2 suppliers
Lot 14cancelled

Dalteparin Injections

Award value

Start

End

Estimated

£17.4m

CPV

33600000
Awarded to 1 supplier
Lot 15cancelled

Tinzaparin Sodium Injections

Award value

Start

End

Estimated

£837k

CPV

33600000
Lot 16cancelled

Icatibant Solution for Injection

Award value

Start

End

Estimated

£381k

CPV

33600000
Lot 17cancelled

Treprostinil Injection

Award value

Start

End

Estimated

£284k

CPV

33600000
Awarded to 1 supplier
Lot 18cancelled

Direct Acting Oral Anticoagulants (DOACs)

Award value

Start

End

Estimated

£12.1m

CPV

33600000